Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: USITC Commissions Determination

E-mail I received today

The Commission’s determination on whether to review the final ID in 337-853 is November 25, 2014.

Jean Jackson

Assistant General Counsel

USITC

Share
New Message
Please login to post a reply